Clinical Trial Update: Satraplatin for Patients With Metastatic Breast Cancer (MBC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for satraplatin in metastatic breast cancer, noting the study status as completed and sponsored by Agennix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• satraplatin (satraplatin)

Snippet

Sponsor: Agennix | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED